These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 31939053
1. ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites. Connors N, Kosnett MJ, Kulig K, Nelson LS, Stolbach AI. J Med Toxicol; 2020 Apr; 16(2):240-242. PubMed ID: 31939053 [No Abstract] [Full Text] [Related]
2. Detection and quantification of low concentrations of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from minimal amounts of urine. Musshoff F, Daldrup T. Int J Legal Med; 1991 Apr; 104(5):263-6. PubMed ID: 1664232 [Abstract] [Full Text] [Related]
3. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2. Fraser AD, Worth D. Forensic Sci Int; 2003 Apr 23; 133(1-2):26-31. PubMed ID: 12742686 [Abstract] [Full Text] [Related]
4. Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. Jamerson MH, McCue JJ, Klette KL. J Anal Toxicol; 2005 Oct 23; 29(7):627-31. PubMed ID: 16419391 [Abstract] [Full Text] [Related]
5. Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite. Kroner GM, Johnson-Davis KL, Doyle K, McMillin GA. J Appl Lab Med; 2020 May 01; 5(3):569-574. PubMed ID: 32445358 [Abstract] [Full Text] [Related]
6. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. Smith ML, Barnes AJ, Huestis MA. J Anal Toxicol; 2009 May 01; 33(4):185-9. PubMed ID: 19470219 [Abstract] [Full Text] [Related]
9. Interpretation of urine quantitative 11-nor-delta-9 tetrahydrocannabinol-9-carboxylic acid to determine abstinence from marijuana smoking. Bell R, Taylor EH, Ackerman B, Pappas AA. J Toxicol Clin Toxicol; 1989 May 01; 27(1-2):109-15. PubMed ID: 2549268 [Abstract] [Full Text] [Related]
10. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Drug Alcohol Depend; 2018 Jan 01; 182():1-7. PubMed ID: 29112827 [Abstract] [Full Text] [Related]
11. [Detection of the metabolite of delta-9-tetrahydrocannabinol in urine by means of GC/MS and interpretation of analytical findings]. Balíková M, Maresová V. Soud Lek; 1996 Dec 01; 41(4):36-40. PubMed ID: 16841441 [Abstract] [Full Text] [Related]
12. Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry. Jamerson MH, Welton RM, Morris-Kukoski CL, Klette KL. J Anal Toxicol; 2005 Oct 01; 29(7):664-8. PubMed ID: 16419397 [Abstract] [Full Text] [Related]
13. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. Huestis MA, Cone EJ. J Anal Toxicol; 1998 Oct 01; 22(6):445-54. PubMed ID: 9788519 [Abstract] [Full Text] [Related]
14. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults. Schlienz NJ, Cone EJ, Herrmann ES, Lembeck NA, Mitchell JM, Bigelow GE, Flegel R, LoDico CP, Hayes ED, Vandrey R. J Anal Toxicol; 2018 May 01; 42(4):232-247. PubMed ID: 29300962 [Abstract] [Full Text] [Related]
15. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice]. Hanke M, Megges G. Z Rechtsmed; 1983 May 01; 90(2):105-8. PubMed ID: 6312709 [Abstract] [Full Text] [Related]
17. Evaluating the impact of hemp food consumption on workplace drug tests. Leson G, Pless P, Grotenhermen F, Kalant H, ElSohly MA. J Anal Toxicol; 2001 May 01; 25(8):691-8. PubMed ID: 11765026 [Abstract] [Full Text] [Related]
18. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users. Lewis J, Molnar A, Allsop D, Copeland J, Fu S. Int J Legal Med; 2016 Jan 01; 130(1):147-52. PubMed ID: 26233612 [Abstract] [Full Text] [Related]
19. Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial. Dahlgren MK, Sagar KA, Lambros AM, Smith RT, Gruber SA. JAMA Psychiatry; 2021 Mar 01; 78(3):335-337. PubMed ID: 33146684 [Abstract] [Full Text] [Related]